Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-006508

Options or other derivatives

  • Exec. Director, Finance - PAO acquired 4,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jones Michael L · Exec. Director, Finance - PAO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-14 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +4,900 4,900 D
Loading xslF345X03/form4.xml…